These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 22100297)

  • 1. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.
    Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M
    J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
    Smoczynski M; Jablonska A; Matyskiel A; Lakomy J; Dubowik M; Marek I; Biernat W; Limon J
    Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
    Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
    Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
    Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
    Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas.
    DeHaan RD; Kipp BR; Smyrk TC; Abraham SC; Roberts LR; Halling KC
    Hum Pathol; 2007 Mar; 38(3):491-9. PubMed ID: 17239935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis.
    Baroud S; Sahakian AJ; Sawas T; Storm AC; Martin JA; Abu Dayyeh BK; Topazian MD; Levy MJ; Roberts LR; Gores GJ; Petersen BT; Chandrasekhara V
    Gastrointest Endosc; 2022 May; 95(5):884-892. PubMed ID: 34871554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures.
    Brooks C; Gausman V; Kokoy-Mondragon C; Munot K; Amin SP; Desai A; Kipp C; Poneros J; Sethi A; Gress FG; Kahaleh M; Murty VV; Sharaiha R; Gonda TA
    Dig Dis Sci; 2018 Mar; 63(3):636-644. PubMed ID: 29353443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
    Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U
    Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
    Liew ZH; Loh TJ; Lim TKH; Lim TH; Khor CJL; Mesenas SJ; Kong CSC; Ong WC; Tan DMY
    J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
    Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
    Quinn KP; Tabibian JH; Lindor KD
    Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic implications of DNA ploidy and S-phase evaluation in the assessment of malignancy in biliary strictures.
    Lindberg B; Enochsson L; Tribukait B; Arnelo U; Bergquist A
    Endoscopy; 2006 Jun; 38(6):561-5. PubMed ID: 16802266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: a single-center, prospective study.
    Ramchandani M; Reddy DN; Gupta R; Lakhtakia S; Tandan M; Darisetty S; Sekaran A; Rao GV
    Gastrointest Endosc; 2011 Sep; 74(3):511-9. PubMed ID: 21737076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.
    Fritcher EG; Kipp BR; Halling KC; Oberg TN; Bryant SC; Tarrell RF; Gores GJ; Levy MJ; Clayton AC; Sebo TJ; Roberts LR
    Gastroenterology; 2009 Jun; 136(7):2180-6. PubMed ID: 19232347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization compared with conventional cytology for the diagnosis of malignant biliary tract strictures in Asian patients.
    Chaiteerakij R; Barr Fritcher EG; Angsuwatcharakon P; Ridtitid W; Chaithongrat S; Leerapun A; Baron TH; Kipp BR; Henry MR; Halling KC; Rerknimitr R; Roberts LR
    Gastrointest Endosc; 2016 Jun; 83(6):1228-35. PubMed ID: 26684604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.